Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The cyclopentenone 15-deoxy-12,14-prostaglandin J2 binds to and activates H-Ras
José Luis Oliva*,,
Dolores Pérez-Sala,,,
Antonio Castrillo,¶,
Natalia Martínez*,
F. Javier Cañada,
Lisardo Boscá¶, and
José M. Rojas*,
*Unidad de Biología Celular, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain; Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28006 Madrid, Spain; and ¶Instituto de Bioquímica and Centro Nacional de Investigaciones Cardiovasculares, Centro Mixto Consejo Superior de Investigaciones Científicas–Universidad Complutense de Madrid, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain
Received for publication September 26, 2002.
Abstract:
The cyclopentenone 15-deoxy-12,14-prostaglandin J2 (15d-PGJ2)induces cell proliferation and mitogen-activated protein kinaseactivation. Here, we describe that these effects are mediatedby 15d-PGJ2-elicited H-Ras activation. We demonstrate that thispathway is specific for H-Ras through the formation of a covalentadduct of 15d-PGJ2 with Cys-184 of H-Ras, but not with N-Rasor K-Ras. Mutation of C184 inhibited H-Ras modification andactivation by 15d-PGJ2, whereas serum-elicited stimulation wasnot affected. These results describe a mechanism for the activationof the Ras signaling pathway, which results from the chemicalmodification of H-Ras by formation of a covalent adduct withcyclopentenone prostaglandins.
Key Words: mitogen-activated protein kinase||cell proliferation||posttranslational modification
J.L.O., D.P.-S., and A.C. contributed equally to this work.
To whom correspondence should be addressed. E-mail: dperezsala{at}cib.csic.esor jmrojas{at}isciii.es.
Edited by Edward M. Scolnick, Merck & Co., Inc., West Point,PA, and approved February 7, 2003
This paper was submitted directly (Track II) to the PNAS office.
The editors suggest the following Related Resources on Science sites:
Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function.
J. R. Springstead, B. G. Gugiu, S. Lee, S. Cha, A. D. Watson, and J. A. Berliner (2012)
J. Lipid Res.
53, 1304-1315
|Abstract »|Full Text »|PDF »
Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis.
J. R. Burgoyne, D. J. Haeussler, V. Kumar, Y. Ji, D. R. Pimental, R. S. Zee, C. E. Costello, C. Lin, M. E. McComb, R. A. Cohen, et al. (2012)
FASEB J
26, 832-841
|Abstract »|Full Text »|PDF »
Functional Specificity of Ras Isoforms: So Similar but So Different.
The Anti-inflammatory Prostaglandin 15-Deoxy-{Delta}12,14-PGJ2 Inhibits CRM1-dependent Nuclear Protein Export.
M. Hilliard, C. Frohnert, C. Spillner, S. Marcone, A. Nath, T. Lampe, D. J. Fitzgerald, and R. H. Kehlenbach (2010)
J. Biol. Chem.
285, 22202-22210
|Abstract »|Full Text »|PDF »
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
L. M. I. Koharudin, H. Liu, R. Di Maio, R. B. Kodali, S. H. Graham, and A. M. Gronenborn (2010)
PNAS
107, 6835-6840
|Abstract »|Full Text »|PDF »
15-Deoxy-{Delta}12,14-Prostaglandin J2 Biphasically Regulates the Proliferation of Mouse Hippocampal Neural Progenitor Cells by Modulating the Redox State.
15-Deoxy-{Delta}12,14-prostaglandin J2 Impairs Phosphatidylcholine Synthesis and Induces Nuclear Accumulation of Thiol-modified Cytidylyltransferase.
A. J. Ryan, B. B. Chen, P. R. Vennalaganti, F. C. Henderson, L. A. Tephly, A. B. Carter, and R. K. Mallampalli (2008)
J. Biol. Chem.
283, 24628-24640
|Abstract »|Full Text »|PDF »
Regulation of TLR2 Expression by Prostaglandins in Brain Glia.
H. J. Yoon, S.-B. Jeon, I.-H. Kim, and E. J. Park (2008)
J. Immunol.
180, 8400-8409
|Abstract »|Full Text »|PDF »
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-{alpha} via Covalent Modification of DNA-Binding Domain.
H.-J. Kim, J.-Y. Kim, Z. Meng, L. H. Wang, F. Liu, T. P. Conrads, T. R. Burke, T. D. Veenstra, and W. L. Farrar (2007)
Cancer Res.
67, 2595-2602
|Abstract »|Full Text »|PDF »
PPAR{gamma}1 attenuates cytosol to membrane translocation of PKC{alpha} to desensitize monocytes/macrophages.
A. von Knethen, M. Soller, N. Tzieply, A. Weigert, A. M. Johann, C. Jennewein, R. Kohl, and B. Brune (2007)
J. Cell Biol.
176, 681-694
|Abstract »|Full Text »|PDF »
Protection of RPE Cells from Oxidative Injury by 15-Deoxy-{Delta}12,14-Prostaglandin J2 by Augmenting GSH and Activating MAPK.
S. Qin, A. P. McLaughlin, and G. W. De Vries (2006)
Invest. Ophthalmol. Vis. Sci.
47, 5098-5105
|Abstract »|Full Text »|PDF »
Nrf2-mediated Induction of Cytoprotective Enzymes by 15-Deoxy-{Delta}12,14-Prostaglandin J2 Is Attenuated by Alkenal/one Oxidoreductase.
X. Yu, P. A. Egner, J. Wakabayashi, N. Wakabayashi, M. Yamamoto, and T. W. Kensler (2006)
J. Biol. Chem.
281, 26245-26252
|Abstract »|Full Text »|PDF »
Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases.
A. Alfranca, M. A. Iniguez, M. Fresno, and J. M. Redondo (2006)
Cardiovasc Res
70, 446-456
|Abstract »|Full Text »|PDF »
Potentiation of tumor formation by topical administration of 15-deoxy-{Delta}12,14-prostaglandin J2 in a model of skin carcinogenesis.
O. Millan, D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Perez-Sala, J. M. Rojas, A. Cano, and L. Bosca (2006)
Carcinogenesis
27, 328-336
|Abstract »|Full Text »|PDF »
Identification of Novel Protein Targets for Modification by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Mesangial Cells Reveals Multiple Interactions with the Cytoskeleton.
K. Stamatakis, F. J. Sanchez-Gomez, and D. Perez-Sala (2006)
J. Am. Soc. Nephrol.
17, 89-98
|Abstract »|Full Text »|PDF »
{alpha},{beta}-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor {gamma}.
T. Shiraki, N. Kamiya, S. Shiki, T. S. Kodama, A. Kakizuka, and H. Jingami (2005)
J. Biol. Chem.
280, 14145-14153
|Abstract »|Full Text »|PDF »
The mitochondrial respiratory complex I is a target for 15-deoxy-{Delta}12,14-prostaglandin J2 action.
B. Martinez, A. Perez-Castillo, and A. Santos (2005)
J. Lipid Res.
46, 736-743
|Abstract »|Full Text »|PDF »
Protein Thiol Modification by 15-deoxy-{Delta}12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes.
F. J. Sanchez-Gomez, E. Cernuda-Morollon, K. Stamatakis, and D. Perez-Sala (2004)
Mol. Pharmacol.
66, 1349-1358
|Abstract »|Full Text »|PDF »
The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras.
J. L. Oliva, N. Zarich, N. Martinez, R. Jorge, A. Castrillo, M. Azanedo, S. Garcia-Vargas, S. Gutierrez-Eisman, A. Juarranz, L. Bosca, et al. (2004)
J. Biol. Chem.
279, 33480-33491
|Abstract »|Full Text »|PDF »
Inhibition of Activator Protein 1 Activation, Vascular Endothelial Growth Factor, and Cyclooxygenase-2 Expression by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Colon Carcinoma Cells: Evidence for a Redox-Sensitive Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism.
Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-{Delta}12,14-prostaglandin J2.
D. Perez-Sala, E. Cernuda-Morollon, and F. J. Canada (2003)
J. Biol. Chem.
278, 51251-51260
|Abstract »|Full Text »|PDF »
Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins.
T. Shibata, T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, J. Yodoi, and K. Uchida (2003)
J. Biol. Chem.
278, 26046-26054
|Abstract »|Full Text »|PDF »